Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19

Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammatory cytokines involved in the COVID-19 CRS to identify candidate transcription factors (TFs) for thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoso, Clarissa S., Li, Zhaorong, Rottenberg, Jaice T., Liu, Xing, Shen, Vivian X., Fuxman Bass, Juan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215608/
https://www.ncbi.nlm.nih.gov/pubmed/34163359
http://dx.doi.org/10.3389/fphar.2021.673485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215608/
https://www.ncbi.nlm.nih.gov/pubmed/34163359
http://dx.doi.org/10.3389/fphar.2021.673485

Ejemplares similares